History
  • No items yet
midpage
Myla Nauman v. Abbott Laboratories
669 F.3d 854
7th Cir.
2012
Read the full case

Background

  • Abbott spins HPD into Hospira, making Hospira a separate company; HPD employees become Hospira employees.
  • Hospira offers an enhanced 401(k) instead of a pension; pre-spin pension rights in Abbott plan are effectively eliminated for those transitioning.
  • Reciprocal no-hire policies for two years post-spin bar Abbott-Hospira employee movement to protect retention.
  • Retirement-eligible HPD employees could not retire from Abbott to begin pension benefits and then join Hospira.
  • Five key HPD executives receive retention bonuses equal to anticipated future retiree medical benefits to reassure them post-spin.
  • District court bench trial results: judgment for Abbott/Hospira on all counts; plaintiffs appeal.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
ERISA §510 intent to interfere Nauman et al. claim Abbott intended to thwart pension rights via spin and no-hire. Abbott and Hospira contend benefits played no role in the spin/no-hire decisions. No clear error; no evidence of intent to interfere with benefits.
No-hire policy and benefits interference Policy deterred HPD employees from exercising pension rights by precluding post-spin work at Abbott. Policy aimed at post-spin stability and did not target benefits. Policy not motivated to interfere with benefits; no §510 violation.
Hospira benefits design and §510 Hospira's plan design allegedly colluded with Abbott to undermine benefits. Hospira independently set its own post-spin benefits; Abbott had no fiduciary duty to Hospira's plan. Abbott not a fiduciary to Hospira plan; no interference claim.
Breach of fiduciary duty disclosure Abbott failed to disclose Hospira would not offer pension/retiree medical benefits. Abbott truthful that Hospira would create its own plan; statements were accurate. No breach; communications were truthful and plan created post-spin by Hospira.

Key Cases Cited

  • Lindemann v. Mobil Oil Corp., 141 F.3d 290 (7th Cir. 1998) (requires a specific intent to interfere with benefit rights)
  • Isbell v. Allstate Ins. Co., 418 F.3d 788 (7th Cir. 2005) (for § 510, need intent to frustrate benefits)
  • Serwatka v. Rockwell Automation, Inc., 591 F.3d 957 (7th Cir. 2010) (but-for causation considerations in § 510 context)
  • Gross v. FBL Financial Services, Inc., 557 U.S. 167 (U.S. 2009) (but-for causation governs § 510 claims post‑Gross)
  • Serafin v. Local 722, 597 F.3d 908 (7th Cir. 2010) (application of causation standards in ERISA contexts)
  • Beach v. Commonwealth Edison Co., 382 F.3d 656 (7th Cir. 2004) (fiduciary duties are plan-specific)
  • Pegram v. Herdrich, 530 U.S. 211 (U.S. 2000) (fiduciary duty depends on performing fiduciary functions)
Read the full case

Case Details

Case Name: Myla Nauman v. Abbott Laboratories
Court Name: Court of Appeals for the Seventh Circuit
Date Published: Feb 3, 2012
Citation: 669 F.3d 854
Docket Number: 10-2272
Court Abbreviation: 7th Cir.